Ranbaxy Riled By FDA, Currency - Forbes
 Hindu Business Line |
Ranbaxy Riled By FDA, Currency
Forbes, NY - (See "FDA: Ranbaxy Botched Manufacturing") Although the FDA did not actually remove any products from the shelves, or advise consumers to stop buying … Ranbaxy reports Rs 352-cr loss in Q3 on US ban, weak rupee Ranbaxy posts Rs 395-cr loss Ranbaxy incurs Rs.49 million loss in third quarter (Lead) |
More: continued here